3647 results for «819»
3647 results
Leaflet modification techniques: latest acronyms, concepts and best practice
17 Nov 2025 – From PCR London Valves 2025
Gain comprehensive insights into leaflet modification techniques with a focus on the latest acronyms, concepts, and best practices. This session covers step-by-step approaches to transcatheter electrosurgical leaflet modification, including BASILICA, SHORTCUT, and UNICORN, alongside troubleshooting strategies and the innovative SURPLUS surgical technique.
Mitral paravalvular leak closure: procedural planning and step-by-step performance
17 Nov 2025 – From PCR London Valves 2025
This session provides an expert overview of mitral paravalvular leak closure, emphasizing critical clinical and anatomical selection criteria. It covers essential pre-procedural imaging and planning strategies, complemented by an educational recorded case and a review of immediate and long-term procedural outcomes.
Heart Team management of complex valve disease
17 Nov 2025 – From PCR London Valves 2025
Explore the dynamics of managing complex valve disease within a multidisciplinary Heart Team framework. This session discusses strategies for building and sustaining high-functioning teams, integrating multimodality imaging, clinical risk assessment, AI tools, and patient preferences into decision-making, alongside effective communication methods to support collaborative care.
Featured research - TAVI: MELA, ViMech & more
17 Nov 2025 – From PCR London Valves 2025
This session presents cutting-edge research on Transcatheter Aortic Valve Implantation (TAVI), focusing on comparative outcomes between Myval and Evolut valves in large aortic annuli, the role of balloon post-dilation in self- and balloon-expandable valves, and novel valve-in-mechanical valve replacement approaches. Long-term follow-up data contrasting surgical aortic...
Featured research - TAVI: procedural optimization
17 Nov 2025 – From PCR London Valves 2025
Delve into comprehensive analyses of TAVI procedural outcomes and innovations in this session. Topics include the impact of intercoronary angles on coronary overlap with Evolut valves, mechanisms behind superior outcomes with the latest balloon-expandable valves, and predictive modeling of hemodynamics using physics-enhanced digital twins. Additionally, sex-specific...
TAVI complications - Part 2
17 Nov 2025 – From PCR London Valves 2025
This session explores complex and uncommon complications associated with TAVI procedures, highlighting challenging clinical scenarios such as neurological complications in bicuspid valves, management of critically unstable left ventricles, and outcomes in complex valve interventions. Each topic offers valuable lessons for improving procedural safety and patient outcomes...
TAVI: high coronary risk - Part 2
17 Nov 2025 – From PCR London Valves 2025
This session addresses the challenges and solutions related to high coronary risk in TAVI procedures. Topics include advanced coronary protection strategies, innovative approaches to complex valve-in-valve interventions, the benefits of balloon-assisted techniques, management of right coronary cusp obstruction through UNICORN technology, and prevention of sinus sequestration...
Thrombotic complications of transcatheter valves
17 Nov 2025 – From PCR London Valves 2025
Focusing on thrombotic complications following transcatheter valve implantation, this session presents a series of complex cases illustrating acute and late thrombotic events, their clinical presentations, and the pivotal role of multimodality imaging in diagnosis and management. Insights include coronary embolism and cardiogenic shock scenarios, emphasizing challenges...
TAVI: complex vascular access - Part 2
17 Nov 2025 – From PCR London Valves 2025
Focus on complex vascular access challenges in TAVI with this session covering strategies such as the pave and crack technique for inaccessible vessels, management of bicuspid aortic stenosis with hostile access and horizontal aorta, complex single transfemoral access procedures, and combined interventions including left atrial appendage...
TAVI: coronary protection
17 Nov 2025 – From PCR London Valves 2025
This session addresses coronary protection strategies during TAVI procedures, especially in complex scenarios such as valve-in-valve interventions, small annulus, and high-risk anatomy. It covers advanced techniques like BASILICA and bioprosthetic valve fracture, providing expert guidance on overcoming challenges to prevent coronary artery obstruction and optimize procedural...
TAVI: unusual complications - Part 2
17 Nov 2025 – From PCR London Valves 2025
This session reviews unusual and severe complications encountered during TAVI procedures, such as aorto-right ventricular fistula, ventricular perforation, and sinus of Valsalva rupture. It highlights percutaneous treatment successes and endovascular interventions, offering critical insights into managing life-threatening procedural complications effectively.
Challenging transcatheter mitral valve replacement
17 Nov 2025 – From PCR London Valves 2025
Explore the complexities of transcatheter mitral valve replacement (TMVR) with discussions on managing mitral annular calcification, preventing paravalvular leaks in mitral valve-in-ring procedures, strategies for larger valve deployment in large mitral rings, and the evolution of transseptal TMVR providing durable relief for previously untreatable cases.
Iatrogenic atrial septum defect closure: a necessary procedure?
18 Nov 2025 – From PCR London Valves 2025
This session addresses the clinical considerations surrounding iatrogenic atrial septal defects (ASDs) resulting from transseptal procedures. It covers prevention of residual defects, diagnostic evaluation, criteria for closure, procedural timing, and management strategies for related complications, supported by illustrative clinical cases demonstrating decision-making nuances.
TAVI embolisation - Part 1
18 Nov 2025 – From PCR London Valves 2025
This session explores the critical issue of TAVI valve embolisation, presenting real-world cases that emphasize rapid problem-solving and interventional management strategies. Discussions include bailout techniques for embolised valves, managing multiple valve implantations in severe aortic stenosis, and expectations for TAVI in pure aortic regurgitation. The session...
Featured research: imaging innovation and device performance in TAVI
18 Nov 2025 – From PCR London Valves 2025
This session presents featured research on TAVI, highlighting long-term outcomes and innovations in transcatheter aortic valve therapy. It includes registry data on mild paravalvular leak impact, five-year evaluations of the Hydra THV, comparisons between deep learning and manual echocardiographic assessments, pacemaker implantation outcomes post-TAVI, and procedural...
Complications of valve-in-valve TAVI
18 Nov 2025 – From PCR London Valves 2025
This session addresses the complex complications associated with valve-in-valve TAVI procedures. Topics include delayed coronary compromise, unexpected clinical scenarios, the importance of recognizing surgical bioprosthesis types, the dual role of calcium in TAVI, and intricate left ventricular complications that can arise post valve-in-valve interventions.
A new era for aortic regurgitation: how new guidelines and dedicated devices for AR will redefine treatment
18 Nov 2025 – From PCR London Valves 2025
This session examines the evolving treatment landscape for aortic regurgitation (AR) in light of new ESC guidelines and dedicated devices such as the JenaValve Trilogy System. It provides an in-depth look at refined diagnosis, optimized treatment strategies, and presents real-world data and clinical cases that highlight...
TAVI for pure aortic regurgitation: different animal, different challenges, different approaches
17 Nov 2025 – From PCR London Valves 2025
This session delves into the unique anatomical and pathophysiological challenges posed by pure aortic regurgitation and their impact on treatment strategies. It reviews clinical outcomes with established and new transcatheter devices, and presents emerging technologies that promise to advance therapeutic options for this distinct patient population.
Mitral TEER and LAA closure - LIVE Case
17 Nov 2025 – From PCR London Valves 2025
Watch a LIVE case followed by a recorded case regarding a 91-year-old female with permanent AF, LAD PCI three months earlier, and recurrent GID bleeding who presented with symptomatic severe primary mitral regurgitation due to P2 prolapse and flail. CT imaging showed a LAA with a...
From diagnosis to device: decision-making and planning for mitral valve interventions
17 Nov 2025 – From PCR London Valves 2025
This session offers a comprehensive overview of decision-making and procedural planning for transcatheter mitral valve interventions. It emphasizes patient-specific factors, advanced imaging for valve morphology assessment, device selection, and the integration of emerging technologies to tailor optimal treatment strategies for mitral valve disease.
